Cargando…

Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults

The aim of this work is to describe the dynamics of influenza antibodies after vaccination in adults. We conducted a case-cohort serological study in the automobile manufacturing plants of the Renault España S.A. group in Valladolid and Palencia (Spain), including 550 workers (66.9%) previously vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanz-Muñoz, Iván, Lajara, Conrado, Sánchez-Martínez, Javier, Prada-García, Camino, Rojo-Rello, Silvia, Domínguez-Gil, Marta, Fernández-Espinilla, Virginia, Hernán-García, Cristina, Eiros-Bachiller, José M., Caminero-Pérez, Asunción, Marcos-López, Yolanda, Teso-Fernández, Luis, Echarren, José Ignacio, Castrodeza-Sanz, Javier, Eiros, José M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Influenza
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399472/ https://www.ncbi.nlm.nih.gov/pubmed/37528765 http://dx.doi.org/10.1080/21645515.2023.2236537

Ejemplares similares

Attitudes, Perceptions and Practices of Influenza Vaccination in the Adult Population: Results of a Cross-Sectional Survey in Spain
por: Prada-García, Camino, et al.
Publicado: (2022)

The Impact of the COVID-19 Pandemic on Influenza Vaccination Attitudes and Actions in Spain’s Adult Population
por: Prada-García, Camino, et al.
Publicado: (2023)

Immunodominance hierarchy after seasonal influenza vaccination
por: Sánchez-de Prada, Laura, et al.
Publicado: (2022)

Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults
por: Sanz-Muñoz, Iván, et al.
Publicado: (2023)

Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people
por: Sanz-Muñoz, Iván, et al.
Publicado: (2023)

Adjuvants for COVID-19 Vaccines
por: Castrodeza-Sanz, Javier, et al.
Publicado: (2023)

Adjuvanted Influenza Vaccines Elicits Higher Antibody Responses against the A(H3N2) Subtype than Non-Adjuvanted Vaccines
por: Sánchez de Prada, Laura, et al.
Publicado: (2020)

Impact of COVID-19 on Adherence to Treatment in Patients with HIV
por: Carbonero-Lechuga, Pablo, et al.
Publicado: (2023)

Surveillance of COVID-19 after the pandemic. How do we do it?
por: Sanz-Muñoz, Iván, et al.
Publicado: (2022)

Vigilancia de la COVID-19 tras la pandemia. ¿Cómo lo hacemos?
por: Sanz-Muñoz, Iván, et al.
Publicado: (2022)

Do Vaccines Need a Gender Perspective? Influenza Says Yes!
por: Sánchez-de Prada, Laura, et al.
Publicado: (2021)

The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why?
por: Raude, Jocelyn, et al.
Publicado: (2010)

Gap between cognitions and behaviors among children’s guardians of influenza vaccination: The role of social influence and vaccine-related knowledge
por: Wu, Jing, et al.
Publicado: (2023)

Seasonal Influenza Vaccine Allocation in the Canadian Population during a Pandemic
por: Tuite, Ashleigh, et al.
Publicado: (2009)

Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design
por: Zimmerman, Richard K., et al.
Publicado: (2023)

Reply letter to “Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design”
por: Hadigal, Sanjay, et al.
Publicado: (2023)

PREVALENCE OF ANTIBODIES AGAINST INFLUENZA VIRUS IN NON-VACCINATED EQUINES FROM THE BRAZILIAN PANTANAL
por: Silva, Lucas Gaíva E, et al.
Publicado: (2014)

Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials
por: Zhao, Xiahong, et al.
Publicado: (2016)

Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season
por: Amicizia, Daniela, et al.
Publicado: (2023)

Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis
por: Wei, Xia, et al.
Publicado: (2023)

Influenza vaccine coverage in 6months-64 years-old patients affected by chronic diseases: A retrospective cohort study in Italy
por: Bianchi, Francesco Paolo, et al.
Publicado: (2023)

Parental intention to vaccinate children against seasonal influenza in the Eastern Mediterranean region: A cross-sectional study using the health belief model
por: Fadl, Noha, et al.
Publicado: (2023)

Knowledge, attitudes, concern, behaviors, and barriers associated with the readiness to receive seasonal influenza vaccine among healthcare workers in oncology setting during the COVID-19 pandemic
por: Mubarak, Sawsan, et al.
Publicado: (2023)

Critical paths in a metapopulation model of H1N1: Efficiently delaying influenza spreading through flight cancellation
por: Marcelino, Jose, et al.
Publicado: (2012)

Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses
por: Sánchez-de Prada, Laura, et al.
Publicado: (2021)

Estimating the impact of influenza vaccination of low-risk 50–64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK
por: Nguyen, Van Hung, et al.
Publicado: (2023)

Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial
por: Chen, Jianmin, et al.
Publicado: (2023)

Elección de vacuna antigripal en personas mayores de 65 años. Análisis de informes de comités asesores de vacunación internacionales
por: Pérez-Rubio, Alberto, et al.
Publicado: (2021)

Social Distancing, Lockdown and the Wide Use of Mask; A Magic Solution or a Double-Edged Sword for Respiratory Viruses Epidemiology?
por: Sanz-Muñoz, Ivan, et al.
Publicado: (2021)

Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture–derived H5N1 (aH5n1c) influenza vaccine in adults and older adults
por: Frey, Sharon S., et al.
Publicado: (2023)

The PHH-1V HIPRA vaccine: a new tool in the vaccination strategy against COVID-19
por: Borralleras, Cristina, et al.
Publicado: (2023)

Heterologous Humoral Response against H5N1, H7N3, and H9N2 Avian Influenza Viruses after Seasonal Vaccination in a European Elderly Population
por: Sanz, Ivan, et al.
Publicado: (2017)

The truncated IFITM3 facilitates the humoral immune response in inactivated influenza vaccine-vaccinated mice via interaction with CD81
por: Xie, Qian, et al.
Publicado: (2023)

Protecting pregnant people & infants against influenza: A landscape review of influenza vaccine hesitancy during pregnancy and strategies for vaccine promotion
por: Regan, Annette K., et al.
Publicado: (2022)

Characterizing the dynamics of BCR repertoire from repeated influenza vaccination
por: Mai, Guoqin, et al.
Publicado: (2023)

Identification of Influenza Cases During the H1N1 Pandemic in Massachusetts Using Population-Based Hospital Discharge Data
por: Placzek, Hilary, et al.
Publicado: (2011)

Applying a New Model for Sharing Population Health Data to National Syndromic Influenza Surveillance: DiSTRIBuTE Project Proof of Concept, 2006 to 2009
por: Olson, Donald R, et al.
Publicado: (2011)

Prevalence and risk factors for swine influenza virus infection in the English pig population
por: Mastin, Alexander, et al.
Publicado: (2011)

Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo
por: Fedichev, Peter, et al.
Publicado: (2011)

Top-hits for H1N1pdm Identified by Virtual Screening Using Ensemble-based Docking
por: Nguyen, Hung, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_350do0m3ain3r5cmitlpp90le0